Trump - President, how to make money?
Donald Trump will change America, we believe it! For a long time the US economy and, as a consequence, the stock market has been provided stimulus measures and the further, the less effective these measures become. The coming to power of the Trump allow for a comprehensive reform, which could radically change the situation, and thus to create new growth drivers for entire sectors and the economy as a whole.
1. Tax reform and the return of business to the United States. Trump not only encourages the transfer of business back to the US, but also promises to reduce the tax rate and support to stimulate the process. This, according to our forecasts, will have a positive impact on many US companies that agree to cooperate with the new president, for example, the Ford , Bank of America and Apple's .
2. Control of the pharmaceutical industry. A number of scandals and attacks the politicians greatly collapses capitalization pharmaceutical companies. I do not stay aside and Trump - he, like a true businessman, plans to optimize public spending on health care and monitor the pricing of essential drugs. With one but: strict control, according to our estimates, it will be only for older drugs for which patent holders to raise prices without any reason, new drugs should not touch it because the development costs. We recommend to pay attention to leaders of the pharmaceutical industry - of Pfizer and by Gilead , which annually are working on dozens of innovative drugs for the treatment and continuation of life.
3. Improving relations with Russia. Chances are that in the near future Russia and the West will go in a new way. Removal of sanctions, international cooperation, etc. Will provide a new flow of foreign investment in the domestic market. In our opinion, first of all the shares of the largest companies will be in demand, such as Gazprom , Sberbank and Rostelecom .
Shamil Kuramshin
Investment Analyst Freedom24.ru
20/1/17
https://freedom24.ru/news/i/6933/
"I love doing a lot of things I'm told I can't do. I think that's what drives me and keeps me awake every day." ~ Patrick Soon Shiong
Recent FRHC News
- Freedom Holding Corp. CEO, Timur Turlov, to Deliver Keynote Speech at LD Micro Inaugural New York Investor Conference • Business Wire • 04/01/2024 11:30:00 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/06/2024 09:01:17 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 03/06/2024 06:57:50 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/29/2024 12:00:24 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/13/2024 01:00:18 PM
- Freedom Holding Corp. Reports Third Quarter Fiscal Year 2024 Financial Results • Business Wire • 02/12/2024 02:35:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 02/09/2024 10:11:01 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/25/2024 09:16:05 PM
- Freedom Holding Corp. Announces Completion of External Review of Allegations Made in Short-Seller Report • Business Wire • 01/25/2024 09:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/01/2023 03:15:32 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/20/2023 09:05:16 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 11/17/2023 10:29:19 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 11/17/2023 10:22:26 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/08/2023 11:30:48 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/06/2023 12:55:49 PM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 11/03/2023 05:47:26 PM
- Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 11/03/2023 12:36:25 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 10/12/2023 09:06:19 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 10/10/2023 01:10:53 PM
- Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 09/11/2023 01:56:22 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 09/11/2023 01:54:57 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/24/2023 05:43:52 PM
- Rosca Scarlato Investor Lawyers Investigating • PR Newswire (US) • 08/16/2023 07:10:00 PM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM